Cost-Effectiveness of Behavior Activation Versus Supportive Therapy on Adherence to Eye Exams in Older African Americans With Diabetes.
Publication/Presentation Date
1-1-2017
Abstract
Although the importance of ophthalmologic screening in diabetic patients is widely recognized by clinicians, the cost-effectiveness of strategies aimed at improving eye care utilization in this population is not well established. A cost-effectiveness analysis was performed comparing behavior activation (BA) to supportive therapy (ST) in activating patients to receive a dilated fundus exam (DFE) and promoting healthy management of diabetes. Two hundred six subjects were randomized to receive either BA or ST between 2009 and 2013. Cost-effectiveness was calculated as incremental cost-effectiveness ratio (ICER) of BA versus ST. Total costs for BA and ST per participant were $259.02 and $216.12, respectively. At the 6-month follow-up, 87.91% of BA subjects received a DFE compared to 34.48% of ST subjects. The ICER for BA versus ST was $80.29/percent increase in DFE rate. In terms of improving DFE rates, BA was found to be more cost-effective than ST.
Volume
32
Issue
6
First Page
661
Last Page
667
ISSN
1555-824X
Published In/Presented At
Winters, D., Casten, R., Rovner, B., Murchison, A., Leiby, B. E., Haller, J. A., Hark, L., Weiss, D. M., & Pizzi, L. T. (2017). Cost-Effectiveness of Behavior Activation Versus Supportive Therapy on Adherence to Eye Exams in Older African Americans With Diabetes. American journal of medical quality : the official journal of the American College of Medical Quality, 32(6), 661–667. https://doi.org/10.1177/1062860616680290
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
27884979
Department(s)
Administration and Leadership
Document Type
Article